SUMMARY A dose response study of the effect on gastric acid secretion of synthetic human gastrin-17 in doses of 50, 200, and 500 ng/kg/h was performed in eight healthy volunteers and in eight patients with duodenal ulcer. The study was repeated on a separate day during intravenous infusion of calcium gluconate (0.1 mmol Ca +/kg/h). In healthy subjects the acid response to the combined infusion of synthetic human gastrin and calcium did not significantly exceed the response to synthetic human gastrin alone, in contrast with patients with duodenal ulcer in whom the combined infusion did significantly improve acid output compared with infusion of synthetic human gastrin alone. The dose of synthetic human gastrin required for half maximal acid response (D50) was reduced in both groups but significantly more in patients with duodenal ulcer.
No difference in serum gastrin concentrations or in serum calcium concentrations were found. It is hypothesised that extracellular calcium plays a role in gastrin stimulated acid secretion in man and that patients with duodenal ulcer are more sensitive to this calcium dependent mechanism than non-duodenal ulcer subjects.
Calcium may participate in the stimulation of gastric acid secretion in man by a dual mechanism -that is, by gastrin release' 2 and by an action directly on the parietal cell.1 3 In previous studies it was found that calcium increases the sensitivity of the parietal cells to synthetic human gastrin in healthy subjects .3 Furthermore, that administration of verapamil decreases the sensitivity of the parietal cells to gastrin, suggesting that influx of calcium into the parietal cells is an essential step in the acid secretory process.
The aim of the present study has been to investigate whether calcium dependence of the parietal cells is quantitatively different in normal subjects and patients with duodenal ulcer.
Methods

SUBJECTS
Nine healthy volunteers (five men and four women, aged 21-38 years) and nine patients with duodenal ulcer (six men and three women, aged 26-48 years) were studied. Each subject was studied twice on separate days. All gave informed consent.
On the first day, synthetic human gastrin-17 (SHG, Imperial Chemical Industries, Cheshire, England) was infused. After an overnight fast, a Levin tube was placed in the stomach under fluoroscopic control. Intermittent mechanical suction producing a subatmospheric pressure of 150 mmHg was used in the collection of the secretion. Through a thin polyvinyl tube welded to the Levin tube, a marker substance was instilled into the stomach (51Cr-EDTA, flow 30 ml/h) to determine recovery. The opening in the polyvinyl tube was 10 cm proximal to the most proximal opening in the Levin tube. The volume of secretion collected was measured for each 15 minute period, and the concentration of H+ and 51Cr-EDTA determined. Synthetic human gastrin was administered by continuous intravenous infusion in doses of 50, 200, and 500 ng/kg/h; each dose was administered for one hour.
On the second day, the experiment was repeated on a backfround infusion of calcium gluconate (0.1 mmol Ca /kg/h). Infusion of calcium started one hour before the infusion of synthetic human gastrin and continued throughout the experiment -that is, for four hours. Calcium gluconate for infusion was prepared by the hospital's pharmaceutical department in a concentration of 0*66 mmol/ml of Ca2+.
For further dilution, 0-9% saline was used.
LABORATORY ANALYSIS
The concentration of H+ was determined by titration with an autotitrator (Radiometer, Copenhagen) to pH 7 0. The concentration of 51Cr-EDTA was determined in a well counter. The volume of the secretion and the output of H+ were corrected to the actual recovery by the marker substance instilled. Repeated estimations of osmolarity by freezing point reduction were taken as an index of the degree of duodenal reflux.5 Serum calcium concentration was determined by atomic absorption spectrophotometry and serum gastrin concentration was measured radioimmunochemically.6 CALCULATIONS Correction for non-recovered gastric juice was done for every 15 minute sample according to the formula: 
Results
Acid secretion in the control subjects is shown in Fig. 1 and in patients with duodenal ulcer in Fig. 2 . In healthy subjects calcium increased the acid response to the lowest dose of synthetic human gastrin (50 ng/kg/h) significantly, whereas the integrated acid output over the total dose range of synthetic human gastrin was not significantly increased. This is in contrast with findings in duodenal ulcer patients where calcium significantly increased the integrated acid output to synthetic human gastrin.
Calculated maximal response and D50 are shown in Table 1 between control subjects and patients with duodenal ulcer. Calcium infusion did not alter calculated maximal response in healthy subjects, whereas calculated maximal response was non-significantly increased in patients with duodenal ulcer. D50 was reduced significantly in both groups, 55% in patients with duodenal ulcer and 29% in the control group. Reduction of D50 was significantly greater in the patients than in the control subjects. Serum gastrin concentrations are shown in Table  2 . No difference was found between patients and control subjects. This is true also for serum calcium concentration (Table 3 ). In gastrin stimulated acid secretion calcium flux across the cell membrane or alteration of membrane calcium may be part of a second effector system,9 a concept which is indirectly supported by our previous studies.3 If this is true the increased sensitivity could be due to an increased sensitivity to calcium or to facilitated influx of calcium into the parietal cell. The present study shows that the same amount of calcium administered to healthy subjects and to patients with duodenal ulcer, significantly increased the acid response to synthetic human gastrin and reduced D50 in the patients.
This finding, as well as previous studies34 support, although indirectly, the view that influx of calcium across or into the cell membrane plays a role for gastrin stimulated acid secretion, and furthermore that patients with duodenal ulcer are more sensitive to this mechanism than healthy subjects. 
